CANCER
Showing ALL that resistance is futile
The combination of venetoclax and dasatinib is synergistically effective in treating Philadelphia chromosome–positive ALL.
J. T. Leonard, J. S. J. Rowley, C. A. Eide, E. Traer, B. Hayes-Lattin, M. Loriaux, S. E. Spurgeon, B. J. Druker, J. W. Tyner, B. H. Chang, Targeting BCL-2 and ABL/LYN in Philadelphia chromosome–positive acute lymphoblastic leukemia. Sci. Transl. Med. 8, 354ra114 (2016). [Abstract]
